Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

043. Clinical Trials: Thursday, 12:15 - 1:30 p.m.

Poster Session: Clinical Trials

(373) An open-label 24-week randomised multicentered clinical trial of Bictegravir/Emtricitabine/Tenofovir Alafenamide compared to Tenofivir/Lamifuvine/Efavirenz as an initial regimen in Chinese late presenters with HIV-1 infection

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Virtual

    Co-Author(s)

  • Lq

    Ling qin, MD

    Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
    Beijing, Beijing, China

  • rl

    ruichao lu, n/a

    Guangxi Zhuang Autonomous Region Longtan Hospital
    Liuzhou, Guangxi, China

  • rw

    rugang wang, n/a

    Dalian Public Health Clinical Center
    Dalian, Liaoning, China

  • yz

    yingquan zhou, n/a

    Lanzhou Pulmonary Hospital Lanzhou
    Lanzhou, Gansu, China

  • hw

    hongxia wei, n/a

    The Second Hospital of Nanjing, Nanjing University of Chinese Medicine
    Nanjing, Jiangsu, China

  • pm

    ping ma, n/a

    Nankai University Second People's Hospital, School of Medicine, Nankai University
    tianjin, Tianjin, China

  • jz

    junyan zhang, n/a

    Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences
    shanghai, Shanghai, China

    • Presenting Author(s)

  • wei lyu, MD PHD

    Physician
    Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
    Beijing, Beijing, China